Hemoptysis epidemiology and demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
The incidence of hemoptysis is approximately 100 per 100,000 individuals in the outpatient setting. There is no enough data on prevalence of hemoptysis. The mortality rate of patients with massive hemoptysis is approximately 50-100%, if left untreated. During 1995-2005, in-hospital mortality rate of massive hemoptysis was 0-15%. Patients of all age groups may develop hemoptysis. There is no racial predilection to hemoptysis. Hemoptysis affects men and women equally. Hemoptysis is a symptom that might affect everyone. Underlying causes of hemoptysis might be different in developed countries than in developing countries. In the United States, incidence of tuberculosis in patients with massive hemoptysis is 7%, while in south africa it is 85%.
Epidemiology and Demographics
Incidence
- The incidence of hemoptysis is approximately 100 per 100,000 individuals in the outpatient setting.[1]
Prevalence
- There is no enough data on prevalence of hemoptysis.
Case-fatality rate/Mortality rate
- The mortality rate of patients with massive hemoptysis is approximately 50-100%, if left untreated.[2][3]
- During 2000-2005, in-hospital mortality rate of massive hemoptysis was 0%.[4]
- During 1995-1999, in-hospital mortality rate of massive hemoptysis was 15%.[4]
Age
- Patients of all age groups may develop hemoptysis.
Race
- There is no racial predilection to hemoptysis.
Gender
- Hemoptysis affects men and women equally.
Region
- Hemoptysis is a symptom that might affect everyone.
Developed Countries
- Underlying causes of hemoptysis might be different in developed countries.
- In the United States, incidence of tuberculosis in patients with massive hemoptysis is 7%.[5]
Developing Countries
- Underlying causes of hemoptysis might be different in developing countries.
- In south africa, incidence of tuberculosis in patients with massive hemoptysis is 85%.[5]
References
- ↑ Jones, R.; Charlton, J.; Latinovic, R.; Gulliford, M. C (2009). “Alarm symptoms and identification of non-cancer diagnoses in primary care: cohort study”. BMJ. 339 (aug13 2): b3094–b3094. doi:10.1136/bmj.b3094. ISSN 0959-8138.
- ↑ Shigemura, Norihisa; Wan, Innes Y.; Yu, Simon C.H.; Wong, Randolph H.; Hsin, Michael K.Y.; Thung, Hoi K.; Lee, Tak-Wai; Wan, Song; Underwood, Malcolm J.; Yim, Anthony P.C. (2009). “Multidisciplinary Management of Life-Threatening Massive Hemoptysis: A 10-Year Experience”. The Annals of Thoracic Surgery. 87 (3): 849–853. doi:10.1016/j.athoracsur.2008.11.010. ISSN 0003-4975.
- ↑ Noë, G.D.; Jaffé, S.M.; Molan, M.P. (2011). “CT and CT angiography in massive haemoptysis with emphasis on pre-embolization assessment”. Clinical Radiology. 66 (9): 869–875. doi:10.1016/j.crad.2011.03.001. ISSN 0009-9260.
- ↑ 4.0 4.1 Sakr, L.; Dutau, H. (2010). “Massive Hemoptysis: An Update on the Role of Bronchoscopy in Diagnosis and Management”. Respiration. 80 (1): 38–58. doi:10.1159/000274492. ISSN 1423-0356.
- ↑ 5.0 5.1 Earwood JS, Thompson TD (2015). “Hemoptysis: evaluation and management”. Am Fam Physician. 91 (4): 243–9. PMID 25955625.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH